Proskorovsky, Irina
Benedict, Agnes
Negrier, Sylvie
Bargo, Danielle
Sandin, Rickard
Ramaswamy, Krishnan
Desai, Jigar
Cappelleri, Joseph C.
Larkin, James
Funding for this research was provided by:
Pfizer
Article History
Received: 25 May 2018
Accepted: 29 November 2018
First Online: 19 December 2018
Ethics approval and consent to participate
: Ethics approval and written informed consent to participate were not obtained because of the retrospective nature of this study.
: Not applicable.
: KR, JCC, RS, and DB are employees of Pfizer and own stock. JD was an employee of Pfizer at the time of the study. SN reports that, outside of the submitted work, she has received honoraria from BMS, Ipsen, Novartis, EUSA Pharma, and Pfizer. JL reports that, outside the submitted work, he has received personal fees and grants from BMS, MSD, Novartis, and Pfizer. He further reports receipt of personal fees from Eisai, GSK, Kymab, Roche/Genentech, Secama, Pierre Fabre, and EUSA Pharma. IP and AB are employed by Evidera, which received funding from Pfizer to participate in the study and the development of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.